Abstract
During the past 25 years, the combination of increasingly sophisticated gene targeting technology with transplantation techniques has allowed researchers to address a wide array of questions about postnatal mammary gland development. These in turn have significantly contributed to our knowledge of other branched epithelial structures. This review chapter highlights a selection of the mouse models exhibiting a pubertal mammary gland phenotype with a focus on how they have contributed to our overall understanding of in vivo mammary morphogenesis. We discuss mouse models that have enabled us to assign functions to particular genes and proteins and, more importantly, have determined when and where these factors are required for completion of ductal outgrowth and branch patterning. The reason for the success of the mouse mammary gland model is undoubtedly the suitability of the postnatal mammary gland to experimental manipulation. The gland itself is very amenable to investigation and the combination of genetic modification with accessibility to the tissue has allowed an impressive number of studies to inform biology. Excision of the rudimentary epithelial structure postnatally allows genetically modified tissue to be readily transplanted into wild type stroma or vice versa, and has thus defined the contribution of each compartment to particular phenotypes. Similarly, whole gland transplantation has been used to definitively discern local effects from indirect systemic effects of various growth factors and hormones. While appreciative of the power of these tools and techniques, we are also cognizant of some of their limitations, and we discuss some shortcomings and future strategies that can overcome them.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Couse JF, Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358–417. doi:10.1210/edrv.20.3.0370
Hovey RC, Trott JF, Vonderhaar BK (2002) Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 7:17–38
Bocchinfuso WP, Korach KS (1997) Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2:323–334
Mallepell S, Krust A, Chambon P, Brisken C (2006) Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci U S A 103:2196–2201. doi:10.1073/pnas.0510974103
Feng Y, Manka D, Wagner K-U, Khan SA (2007) Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc Natl Acad Sci U S A 104:14718–14723. doi:10.1073/pnas.0706933104
Manavathi B, Samanthapudi VSK, Gajulapalli VNR (2014) Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development. Front Cell Dev Biol 2:34. doi:10.3389/fcell.2014.00034
Han SJ, DeMayo FJ, Xu J et al (2006) Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol Endocrinol 20:45–55. doi:10.1210/me.2005-0310
Howlin J, McBryan J, Napoletano S et al (2006) CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis. Oncogene 25:1532–1542. doi:10.1038/sj.onc.1209183
Li M, Fu X, Ma G et al (2012) Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling. PLoS One 7, e51283. doi:10.1371/journal.pone.0051283
Li M, Zhao D, Ma G et al (2013) Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. Cancer Cell 430:358–363. doi:10.1016/j.bbrc.2012.11.009
Brisken C, Park S, Vass T et al (1998) A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A 95:5076–5081
Humphreys RC, Lydon JP, O'Malley BW, Rosen JM (1997) Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia 2:343–354
Conneely OM, Mulac-Jericevic B, Lydon JP, De Mayo FJ (2001) Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol Cell Endocrinol 179:97–103
Mulac-Jericevic B, Mullinax RA, DeMayo FJ et al (2000) Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289:1751–1754
Shyamala G, Yang X, Silberstein G et al (1998) Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci U S A 95:696–701
Kleinberg DL (1997) Early mammary development: growth hormone and IGF-1. J Mammary Gland Biol Neoplasia 2:49–57
Ruan W, Kleinberg DL (1999) Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140:5075–5081. doi:10.1210/endo.140.11.7095
Ormandy CJ, Camus A, Barra J et al (1997) Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11:167–178
Ormandy CJ, Binart N, Kelly PA (1997) Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia 2:355–364
Horseman ND, Zhao W, Montecino-Rodriguez E et al (1997) Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926–6935. doi:10.1093/emboj/16.23.6926
Brisken C, Kaur S, Chavarria TE et al (1999) Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 210:96–106. doi:10.1006/dbio.1999.9271
Kingsley-Kallesen M, Mukhopadhyay SS, Wyszomierski SL et al (2002) The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development. Mol Endocrinol 16(9):2008–2018. doi:10.1210/me.2002-0103
Reichardt HM, Horsch K, Grone HJ et al (2001) Mammary gland development and lactation are controlled by different glucocorticoid receptor activities. Eur J Endocrinol 145(4):519–527
Wintermantel TM, Bock D, Fleig V et al (2005) The Epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production. Mol Endocrinol 19(2):340–349. doi:10.1210/me.2004-0068
Dunbar ME, Dann PR, Robinson GW et al (1999) Parathyroid hormone-related protein signaling is necessary for sexual dimorphism during embryonic mammary development. Development 126(16):3485–3493
Hiremath M, Wysolmerski J (2013) Parathyroid hormone-related protein specifies the mammary mesenchyme and regulates embryonic mammary development. J Mammary Gland Biol Neoplasia 18:171–177. doi:10.1007/s10911-013-9283-7
Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG et al (1995) Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 121(11):3539–3547
Dunbar ME, Dann P, Brown CW et al (2001) Temporally regulated overexpression of parathyroid hormone-related protein in the mammary gland reveals distinct fetal and pubertal phenotypes. J Endocrinol 171(3):403–416
Zinser G, Packman K, Welsh J (2002) Vitamin D3 receptor ablation alters mammary gland morphogenesis. Development 129(13):3067–3076
Welsh J (2004) Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr 80(6 Suppl):1721–1724
Soto AM, Sonnenschein C (2010) Environmental causes of cancer: endocrine disruptors as carcinogens. Oncogene 6:363–370. doi:10.1038/nrendo.2010.87
Hilakivi-Clarke L (2014) Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Res 16:208. doi:10.1093/ije/dyl106
Geens T, Aerts D, Berthot C et al (2012) A review of dietary and non-dietary exposure to bisphenol-A. Food Chem Toxicol 50:3725–3740. doi:10.1016/j.fct.2012.07.059
Muñoz-de-Toro M, Markey CM, Wadia PR et al (2005) Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology 146:4138–4147. doi:10.1210/en.2005-0340
Hilakivi-Clarke L, Cho E, Clarke R (1998) Maternal genistein exposure mimics the effects of estrogen on mammary gland development in female mouse offspring. Oncol Rep 5:609–625. doi:10.3892/or.5.3.609
Johnson MD, Kenney N, Stoica A et al (2003) Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9:1081–1084. doi:10.1038/nm902
Hilakivi-Clarke L, Cho E, Raygada M, Kenney N (1997) Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor α, and estrogen receptor antagonist ICI 182,780. J Cell Physiol 170:279–289
Fielden M (2002) Normal mammary gland morphology in pubertal female mice following in utero and lactational exposure to genistein at levels comparable to human dietary exposure. Toxicol Lett 133:181–191. doi:10.1016/S0378-4274(02)00154-6
Wise A, O’Brien K, Woodruff T (2011) Are oral contraceptives a significant contributor to the estrogenicity of drinking water? Environ Sci Technol 45:51–60. doi:10.1021/es1014482
Khan U, Nicell JA (2014) Contraceptive options and their associated estrogenic environmental loads: relationships and trade-offs. PLoS One 9, e92630. doi:10.1371/journal.pone.0092630
McBryan J, Howlin J, Napoletano S, Martin F (2008) Amphiregulin: role in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 13:159–169. doi:10.1007/s10911-008-9075-7
Ciarloni L, Mallepell S, Brisken C (2007) Amphiregulin is an essential mediator of estrogen receptor function in mammary gland development. Proc Natl Acad Sci U S A 104:5455–5460. doi:10.1073/pnas.0611647104
McBryan J, Howlin J, Kenny PA et al (2007) ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis. Oncogene 26:6406–6419. doi:10.1038/sj.onc.1210468
Luetteke NC, Qiu TH, Fenton SE et al (1999) Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126:2739–2750
Sternlicht MD, Sunnarborg SW, Kouros-Mehr H et al (2005) Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132:3923–3933. doi:10.1242/dev.01966
Wiesen JF, Young P, Werb Z, Cunha GR (1999) Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126:335–344
Schroeder JA, Lee DC (1998) Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ 9:451–464
Stern D (2003) ErbBs in mammary development. Exp Cell Res 284:89–98. doi:10.1016/S0014-4827(02)00103-9
Sebastian J, Richards RG, Walker MP et al (1998) Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ 9:777–785
Stern DF (2008) ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 13:215–223. doi:10.1007/s10911-008-9083-7
Jones FE, Welte T, Fu XY, Stern DF (1999) ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol 147:77–88
Long W, Wagner K-U, Lloyd KCK et al (2003) Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130:5257–5268. doi:10.1242/dev.00715
Jackson-Fisher AJ, Bellinger G, Breindel JL et al (2008) ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res 10(6):96. doi:10.1186/bcr2198
Krane IM, Leder P (1996) NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 12:1781–1788
Liu JL, LeRoith D (1999) Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140:5178–5184. doi:10.1210/endo.140.11.7151
Richards RG, Klotz DM, Walker MP, Diaugustine RP (2004) Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I. Endocrinology 145:3106–3110. doi:10.1210/en.2003-1112
Loladze AV, Stull MA, Rowzee AM et al (2006) Epithelial-specific and stage-specific functions of insulin-like growth factor-I during postnatal mammary development. Endocrinology 147:5412–5423. doi:10.1210/en.2006-0427
Richert MM, Wood TL (1999) The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions. Endocrinology 140:454–461. doi:10.1210/endo.140.1.6413
de Ostrovich KK, Lambertz I, Colby JKL et al (2008) Paracrine overexpression of insulin-like growth factor-1 enhances mammary tumorigenesis in vivo. Am J Pathol 173:824–834. doi:10.2353/ajpath.2008.071005
Bonnette SG, Hadsell DL (2001) Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142(11):4937–4945
Jones RA, Campbell CI, Gunther EJ et al (2006) Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation. Oncogene 26:1636–1644. doi:10.1038/sj.onc.1209955
Carboni JM (2005) Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res 65:3781–3787. doi:10.1158/0008-5472.CAN-04-4602
Flint DJ, Tonner E, Beattie J, Allan GJ (2008) Role of insulin-like growth factor binding proteins in mammary gland development. Int J Dev Biol 13:443–453. doi:10.1007/s10911-008-9095-3
Guo L, Degenstein L, Fuchs E (1996) Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 10:165–175
Sekine K, Ohuchi H, Fujiwara M et al (1999) Fgf10 is essential for limb and lung formation. Nat Genet 21:138–141. doi:10.1038/5096
Ngan ESW, Ma Z-Q, Chua SS et al (2002) Inducible expression of FGF-3 in mouse mammary gland. Proc Natl Acad Sci U S A 99:11187–11192. doi:10.1073/pnas.172366199
Lu P, Ewald AJ, Martin GR, Werb Z (2008) Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 321:77–87. doi:10.1016/j.ydbio.2008.06.005
Yant J, Buluwela L, Niranjan B et al (1998) In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp Cell Res 241:476–481. doi:10.1006/excr.1998.4028
Yang Y, Spitzer E, Meyer D et al (1995) Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131:215–226
Garner OB, Bush KT, Nigam KB et al (2011) Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. Dev Biol 355:394–403. doi:10.1016/j.ydbio.2011.04.035
Niranjan B, Buluwela L, Yant J et al (1995) HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121:2897–2908
Delehedde M, Lyon M, Sergeant N et al (2001) Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J Mammary Gland Biol Neoplasia 6:253–273. doi:10.1023/A:1011367423085
Liu BY, Kim YC, Leatherberry V et al (2003) Mammary gland development requires syndecan-1 to create a β-catenin/TCF-responsive mammary epithelial subpopulation. Oncogene 22:9243–9253. doi:10.1038/sj.onc.1207217
Wu Z-ZZ, Sun N-KN, Chao CC-KC (2011) Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis. J Cell Physiol 226:2415–2428. doi:10.1002/jcp.22589
Zcharia E, Jia J, Zhang X et al (2009) Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS One 4, e5181. doi:10.1371/journal.pone.0005181.t002
Huebner RJ, Ewald AJ (2014) Cellular foundations of mammary tubulogenesis. Semin Cell Dev Biol 31:124–131. doi:10.1016/j.semcdb.2014.04.019
Shackleton M, Vaillant F, Simpson KJ et al (2006) Generation of a functional mammary gland from a single stem cell. Nature 439:84–88. doi:10.1038/nature04372
Stingl J, Smalley M, Glukhova M, Bentires-Alj M (2010) Methods in mammary gland development and cancer: the second ENDBC meeting – intravital imaging, genomics, modeling and metastasis. Breast Cancer Res 12:311. doi:10.1186/bcr2630
Phillips S, Prat A, Sedic M et al (2014) Cell-state transitions regulated by SLUG are critical for tissue regeneration and tumor initiation. Stem Cell Rep 2:633–647. doi:10.1016/j.stemcr.2014.03.008
Van Keymeulen A, Rocha AS, Ousset M et al (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature 479:189–193. doi:10.1038/nature10573
Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127:1041–1055. doi:10.1016/j.cell.2006.09.048
Asselin-Labat M-L, Sutherland KD, Barker H et al (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9:201–209. doi:10.1038/ncb1530
Asselin-Labat ML, Sutherland KD, Vaillant F et al (2011) Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol Cell Biol 31:4609–4622. doi:10.1128/MCB.05766-11
Pei X-H, Bai F, Smith MD et al (2009) CDK inhibitor p18INK4c is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Cancer Cell 15:389–401. doi:10.1016/j.ccr.2009.03.004
Pietersen AM, Evers B, Prasad AA et al (2008) Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol 18:1094–1099. doi:10.1016/j.cub.2008.06.070
Kurpios NA, MacNeil L, Shepherd TG et al (2009) The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development. Dev Biol 325:106–121. doi:10.1016/j.ydbio.2008.09.033
Jia Y (2005) Peroxisome proliferator-activated receptor-binding protein null mutation results in defective mammary gland development. J Biol Chem 280:10766–10773. doi:10.1074/jbc.M413331200
Jiang P, Hu Q, Ito M et al (2010) Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc Natl Acad Sci U S A 107:6765–6770. doi:10.1073/pnas.1001814107
Hasegawa N, Sumitomo A, Fujita A et al (2012) Mediator subunits MED1 and MED24 cooperatively contribute to pubertal mammary gland development and growth of breast carcinoma cells. Mol Cell Biol 32:1483–1495. doi:10.1128/MCB.05245-11
Parashurama N, Lobo NA, Ito K et al (2012) Remodeling of endogenous mammary epithelium by breast cancer stem cells. Stem Cells 30:2114–2127. doi:10.1002/stem.1205
Booth BW, Boulanger CA, Anderson LH et al (2010) Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res 316:422–432. doi:10.1016/j.yexcr.2009.11.006
Santos SJ, Haslam SZ, Conrad SE (2010) Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse. Endocrinology 151:2876–2885. doi:10.1210/en.2009-1282
Yamaji D, Na R, Feuermann Y et al (2009) Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 23:2382–2387. doi:10.1101/gad.1840109
Vafaizadeh V, Klemmt PA, Groner B (2012) Stat5 assumes distinct functions in mammary gland development and mammary tumor formation. Front Biosci 17:1232–1250
Vafaizadeh V, Klemmt P, Brendel C et al (2010) Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. Stem Cells 28:928–938. doi:10.1002/stem.407
Rios AC, Fu NY, Lindeman GJ, Visvader JE (2014) In situ identification of bipotent stem cells in the mammary gland. Nature 506:322–327. doi:10.1038/nature12948
Mani SA, Guo W, Liao M-J et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715. doi:10.1016/j.cell.2008.03.027
Bai F, Chan HL, Scott A et al (2014) BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. Cancer Res 74(21):6161–6172
Deng C-X, Xu X, Wagner K-U et al (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37–43. doi:10.1038/8743
Bai F, Smith MD, Chan HL, Pei X-H (2013) Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. Oncogene 32:2715–2725. doi:10.1038/onc.2012.293
Lamber EP, Horwitz AA, Parvin JD (2010) BRCA1 represses amphiregulin gene expression. Cancer Res 70:996–1005. doi:10.1158/0008-5472.CAN-09-2842
Lee K, Gjorevski N, Boghaert E et al (2011) Snail1, Snail2, and E47 promote mammary epithelial branching morphogenesis. EMBO J 30:2662–2674
Nelson CM, Vanduijn MM, Inman JL et al (2006) Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures. Science 314:298–300. doi:10.1126/science.1131000
Kouros-Mehr H, Werb Z (2006) Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn 235:3404–3412. doi:10.1002/dvdy.20978
Nelson CM, Inman JL, Bissell MJ (2008) Three-dimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression. Nat Protoc 3:674–678. doi:10.1038/nprot.2008.35
Ewald AJ, Brenot A, Duong M et al (2008) Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 14:570–581
Jennifer L, Andrews ACKJRH (2012) The role and function of cadherins in the mammary gland. Breast Cancer Res 14:203. doi:10.1186/bcr3065
Daniel CW, Strickland P, Friedmann Y (1995) Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth. Dev Biol 169:511–519. doi:10.1006/dbio.1995.1165
Albergaria A, Ribeiro A-S, Vieira A-F et al (2011) P-cadherin role in normal breast development and cancer. Int J Dev Biol 55:811–822. doi:10.1387/ijdb.113382aa
Delmas V, Pla P, Feracci H et al (1999) Expression of the cytoplasmic domain of E-cadherin induces precocious mammary epithelial alveolar formation and affects cell polarity and cell–matrix integrity. Dev Biol 216:491–506. doi:10.1006/dbio.1999.9517
Boussadia O, Kutsch S, Hierholzer A et al (2002) E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev 115:53–62. doi:10.1016/S0925-4773(02)00090-4
Gallagher RCJ, Hay T, Meniel V et al (2002) Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency. Oncogene 21:6446–6457. doi:10.1038/sj.onc.1205892
Imbert A, Eelkema R, Jordan S et al (2001) Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 153:555–568
Incassati A, Chandramouli A, Eelkema R, Cowin P (2010) Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res 12:213. doi:10.1186/bcr2723
van Genderen C, Okamura R, Farinas I et al (1994) Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8:2691–2703
Wheelock MJ, Shintani Y, Maeda M et al (2008) Cadherin switching. J Cell Sci 121:727–735. doi:10.1242/jcs.000455
Qian X, Karpova T, Sheppard AM et al (2004) E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 23:1739–1784. doi:10.1038/sj.emboj.7600136
Qian X, Anzovino A, Kim S et al (2013) N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties. Oncogene 33:3411–3421. doi:10.1038/onc.2013.310
Baum B, Georgiou M (2011) Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling. J Cell Biol 192(6):907–917
Dow LE, Humbert PO (2007) Polarity Regulators and the Control of Epithelial Architecture, Cell Migration, and Tumorigenesis. International Review of Cytology. Elsevier, Berlin, pp 253–302
Bray K, Gillette M, Young J et al (2013) Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration. Breast Cancer Res 15:91
Gillette M, Bray K, Blumenthaler A, Vargo-Gogola T (2013) P190B RhoGAP overexpression in the developing mammary epithelium induces TGFβ-dependent fibroblast activation. PLoS One 8, e65105. doi:10.1371/journal.pone.0065105
Nathan J et al (2014) Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. PLoS Genet. doi:10.1371/journal.pgen.1004323
Srinivasan K, Strickland P, Valdes A et al (2003) Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell 4:371–382
Munarini N, Jäger R, Abderhalden S et al (2002) Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J Cell Sci 115:25–37
Silberstein G, Daniel C (1987) Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 237:291–293. doi:10.1126/science.3474783
Pierce DF, Johnson MD, Matsui Y et al (1999) Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev 7(12):2308–2317
Ewan KB, Shyamala G, Ravani SA et al (2002) Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol 160:2081–2093
Silberstein GB, Flanders KC, Roberts AB, Daniel CW (1992) Regulation of mammary morphogenesis: evidence for extracellular matrix-mediated inhibition of ductal budding by transforming growth factor-β1. Dev Biol 152:354–362. doi:10.1016/0012-1606(92)90142-4
Roarty K, Serra R (2007) Wnt5a is required for proper mammary gland development and TGF-mediated inhibition of ductal growth. Development 134:3929–3939. doi:10.1242/dev.008250
Vogel WF, Aszódi A, Alves F, Pawson T (2001) Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 21:2906–2917. doi:10.1128/MCB.21.8.2906-2917.2001
Roarty K, Baxley S, Crowley M et al (2009) Loss of TGF-β or Wnt5a results in an increase in Wnt/β-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res 11:R19. doi:10.1186/bcr2244
Silberstein GB (2001) Tumour-stromal interactions. Role of the stroma in mammary development. Breast Cancer Res 3:218–223
Paulsson M (1992) Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 27:93–127. doi:10.3109/10409239209082560
Wiseman BS, Sternlicht MD, Lund LR et al (2003) Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162:1123–1133. doi:10.1083/jcb.200302090
Sympson CJ, Talhouk RS, Alexander CM et al (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125:681–693
Thomasset N, Lochter A, Sympson CJ et al (1998) Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Pathol 153:457–467. doi:10.1016/S0002-9440(10)65589-7
Fata JE, Leco KJ, Moorehead RA et al (1999) Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 211:238–254. doi:10.1006/dbio.1999.9313
Taddei I, Deugnier M-A, Faraldo MM et al (2008) Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 10:716–722. doi:10.1038/ncb1734
Klinowska TC, Soriano JV, Edwards GM et al (1999) Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol 215:13–32. doi:10.1006/dbio.1999.9435
Nagy T, Wei H, Shen T-L et al (2007) Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland. J Biol Chem 282:31766–31776. doi:10.1074/jbc.M705403200
van Miltenburg MHAM, Lalai R, de Bont H et al (2009) Complete focal adhesion kinase deficiency in the mammary gland causes ductal dilation and aberrant branching morphogenesis through defects in Rho kinase-dependent cell contractility. FASEB J 23:3482–3493. doi:10.1096/fj.08-123398
Gomez EW, Chen QK, Gjorevski N, Nelson CM (2010) Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J Cell Biochem 110:44–51. doi:10.1002/jcb.22545
Gjorevski N, Nelson CM (2010) Endogenous patterns of mechanical stress are required for branching morphogenesis. Integr Biol (Camb) 2:424–434. doi:10.1039/c0ib00040j
Gouon-Evans V, Rothenberg ME, Pollard JW (2000) Postnatal mammary gland development requires macrophages and eosinophils. Development 127:2269–2282
Sferruzzi-Perri AN, Robertson SA, Dent LA (2003) Interleukin-5 transgene expression and eosinophilia are associated with retarded mammary gland development in mice. Biol Reprod 69:224–233. doi:10.1095/biolreprod.102.010611
Lilla JN, Werb Z (2010) Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis. Dev Biol 337:124–133. doi:10.1016/j.ydbio.2009.10.021
Van Nguyen A, Pollard JW (2002) Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol 247:11–25. doi:10.1006/dbio.2002.0669
O'Brien J, Martinson H, Durand-Rougely C, Schedin P (2011) Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development 139:269–275. doi:10.1242/dev.071696
Gyorki DE, Asselin-Labat M-L, van Rooijen N et al (2009) Resident macrophages influence stem cell activity in the mammary gland. Breast Cancer Res 11:R62. doi:10.1186/bcr2353
Doyle A, McGarry MP, Lee NA, Lee JJ (2011) The construction of transgenic and gene knockout/knockin mouse models of human disease. Transgenic Res 21:327–349. doi:10.1007/s11248-011-9537-3
Ristevski S (2005) Making better transgenic models: conditional, temporal, and spatial approaches. Mol Biotechnol 29:153–164. doi:10.1385/MB:29:2:153
Medina D (2010) Of mice and women: a short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method. Cold Spring Harb Perspect Biol 2(10):004523
SHILLINGFORD J, Hennighausen L (2001) Experimental mouse genetics – answering fundamental questions about mammary gland biology. Trends Endocrinol Metab 12:402–408. doi:10.1016/S1043-2760(01)00471-4
Fantl V, Stamp G, Andrews A et al (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9(19):2364–2372
Sicinski P, Donaher JL, Parker SB et al (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630. doi:10.1016/0092-8674(95)90034-9
Casimiro MC, Wang C, Li Z et al (2013) Cyclin D1 determines estrogen signaling in the mammary gland in vivo. Mol Endocrinol 27:1415–1428. doi:10.1210/me.2013-1065
Xu J, Liao L, Ning G et al (2000) The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci U S A 97:6379–6384. doi:10.1073/pnas.120166297
Yang Y-A, Tang B, Robinson G et al (2002) Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Cell Growth Differ 13:123–130
Ucar A, Vafaizadeh V, Jarry H et al (2010) miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nat Genet 42:1101–1108. doi:10.1038/ng.709
Remenyi J, van den Bosch MWM, Palygin O et al (2013) miR-132/212 knockout mice reveal roles for these mirnas in regulating cortical synaptic transmission and plasticity. PLoS One 8:62509. doi:10.1371/journal.pone.0062509
Kayo H, Kiga K, Fukuda-Yuzawa Y et al (2014) miR-212 and miR-132 are dispensable for mouse mammary gland development. Nat Genet 46:802–804. doi:10.1038/ng.2990
Ucar A, Erikci E, Ucar O, Chowdhury K (2014) miR-212 and miR-132 are dispensable for mouse mammary gland development. Nat Genet 46:804–805. doi:10.1038/ng.3032
Torres-Ruiz R, Rodriguez-Perales S (2015) CRISPR-Cas9: a revolutionary tool for cancer modelling. Int J Mol Sci 16:22151–22168. doi:10.3390/ijms160922151
Blasco RB, Karaca E, Ambrogio C et al (2014) Simple and rapid in vivo generation of chromosomal rearrangements using CRISPR/Cas9 technology. Cell Rep 9:1219–1227. doi:10.1016/j.celrep.2014.10.051
Maddalo D, Manchado E, Concepcion CP et al (2014) In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 516:423–427. doi:10.1038/nature13902
Sánchez-Rivera FJ, Papagiannakopoulos T, Romero R et al (2014) Rapid modeling of cooperating genetic events in cancer through somatic genome editing. Nature 516:428–431. doi:10.1038/nature13906
Mou H, Kennedy Z, Anderson DG et al (2015) Precision cancer mouse models through genome editing with CRISPR-Cas9. Genome Med 7:53. doi:10.1186/s13073-015-0178-7
Yin H, Xue W, Chen S et al (2014) Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol 32:551–553. doi:10.1038/nbt.2884
Metser G, Shin HY, Wang C et al (2016) An autoregulatory enhancer controls mammary-specific STAT5 functions. Nucleic Acids Res 44(3):1052–1063. doi:10.1093/nar/gkv999
Zhao H, Pearson EK, Brooks DC et al (2012) A humanized pattern of aromatase expression is associated with mammary hyperplasia in mice. Endocrinology 153:2701–2713. doi:10.1210/en.2011-1761
Gallego MI, Binart N, Robinson GW et al (2001) Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 229:163–175. doi:10.1006/dbio.2000.9961
Xu J, Qiu Y, DeMayo FJ et al (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922–1925
Kouros-Mehr H, Kim J-W, Bechis SK, Werb Z (2008) GATA-3 and the regulation of the mammary luminal cell fate. Curr Opin Cell Biol 20:164–170. doi:10.1016/j.ceb.2008.02.003
Zcharia E, Metzger S, Chajek-Shaul T et al (2004) Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J 18(2):252–263
Hathaway HJ, Shur BD (1996) Mammary gland morphogenesis is inhibited in transgenic mice that overexpress cell surface beta1,4-galactosyltransferase. Development 122(9):2859–2872
Steffgen K, Dufraux K, Hathaway H (2002) Enhanced branching morphogenesis in mammary glands of mice lacking cell surface beta1,4-galactosyltransferase. Dev Biol 244:114–133. doi:10.1006/dbio.2002.0599
Crowley MR, Head KL, Kwiatkowski DJ et al (2000) The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis. Dev Biol 225:407–423. doi:10.1006/dbio.2000.9844
Shillingford JM, Miyoshi K, Flagella M (2002) Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: characterization, localization, and involvement in ductal development and morphogenesis. Mol Endocrinol 16(6):1309–1321
Okolowsky N, Furth PA, Hamel PA (2014) Oestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland. Dev Biol 391:219–229. doi:10.1016/j.ydbio.2014.04.007
Vapola MH, Rokka A, Sormunen RT et al (2014) Peroxisomal membrane channel Pxmp2 in the mammary fat pad is essential for stromal lipid homeostasis and for development of mammary gland epithelium in mice. Dev Biol 391:66–80. doi:10.1016/j.ydbio.2014.03.022
Michalak EM, Nacerddine K, Pietersen A et al (2013) Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool. Stem Cells 31:1910–1920
Stairs DB, Notarfrancesco KL, Chodosh LA (2005) The serine/threonine kinase, Krct, affects endbud morphogenesis during murine mammary gland development. Transgenic Res 14:919–940. doi:10.1007/s11248-005-1806-6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
McBryan, J., Howlin, J. (2017). Pubertal Mammary Gland Development: Elucidation of In Vivo Morphogenesis Using Murine Models. In: Martin, F., Stein, T., Howlin, J. (eds) Mammary Gland Development. Methods in Molecular Biology, vol 1501. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6475-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6475-8_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6473-4
Online ISBN: 978-1-4939-6475-8
eBook Packages: Springer Protocols